Literature DB >> 30365555

Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

Sara Costa-Cabral, Rachel Brough, Asha Konde, Marieke Aarts, James Campbell, Eliana Marinari, Jenna Riffell, Alberto Bardelli, Christopher Torrance, Christopher J Lord, Alan Ashworth.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0176578.].

Entities:  

Year:  2018        PMID： 30365555      PMCID： PMC6203384          DOI： 10.1371/journal.pone.0206729

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


There is an error in the Correction published on April 20, 2017. The correct affiliation for the eighth author, Alberto Bartelli, is Candiolo Cancer Institute-FPO, IRCCS, Candiolo, TO, Italy and Department of Oncology, University of Torino, Candiolo, TO 10060, Italy.
  2 in total

1.  Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

Authors:  Sara Costa-Cabral; Rachel Brough; Asha Konde; Marieke Aarts; James Campbell; Eliana Marinari; Jenna Riffell; Alberto Bardelli; Christopher Torrance; Christopher J Lord; Alan Ashworth
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

2.  CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

Authors:  Sara Costa-Cabral; Rachel Brough; Asha Konde; Marieke Aarts; James Campbell; Eliana Marinari; Jenna Riffell; Alberto Bardelli; Christopher Torrance; Christopher J Lord; Alan Ashworth
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240
  2 in total
  1 in total

1.  Seven Glycolysis-Related Genes Predict the Prognosis of Patients With Pancreatic Cancer.

Authors:  Han Nie; Cancan Luo; Kaili Liao; Jiasheng Xu; Xiaozhong Wang
Journal:  Front Cell Dev Biol       Date:  2021-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.